Online citations, reference lists, and bibliographies.
← Back to Search

Stromal Barriers And Strategies For The Delivery Of Nanomedicine To Desmoplastic Tumors.

L. Miao, C. M. Lin, L. Huang
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanoparticle based delivery formulations have become a leading delivery strategy for cancer imaging and therapy. The success of nanoparticle-based therapy relies heavily on their ability to utilize the enhanced permeability and retention (EPR) effect and active targeting moieties to their advantage. However, these methods often fail to enable a uniform NP distribution across the tumor, and lead to insufficient local concentrations of drug. Oftentimes, this heterogeneous drug distribution is one of the primary reasons for suboptimal treatment efficacy in NP delivery platforms. Herein, we seek to examine the biophysical causes of heterogeneous NP distribution in stroma-rich desmoplastic tumors; namely the abnormal tumor vasculature, deregulated extracellular matrix and high interstitial hypertension associated with these tumors. It is suggested that these factors help explain the discrepancy between promising outlooks for many NP formulations in preclinical studies, but suboptimal clinical outcomes for most FDA approved nanoformulations. Furthermore, examination into the role of the physicochemical properties of NPs on successful drug delivery was conducted in this review. In light of the many formidable barriers against successful NP drug delivery, we provided possible approaches to mitigate delivery issues from the perspective of stromal remodeling and NP design. In all, this review seeks to provide guidelines for optimizing nanoparticle-based cancer drug delivery through both modified nanoparticle design and alleviation of biological barriers to successful therapy.
This paper references
Neovasculature induced by vascular endothelial growth factor is fenestrated.
W. Roberts (1997)
10.1016/j.addr.2013.11.011
In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer.
B. R. Seo (2014)
10.1073/pnas.0711345105
In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate
R. Thorne (2008)
10.1038/nnano.2010.58
Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles
Byoung-jin Kim (2010)
10.1146/annurev-bioeng-071813-105259
The role of mechanical forces in tumor growth and therapy.
R. Jain (2014)
10.1016/j.addr.2013.08.010
Nanotechnology and tumor microcirculation.
M. Kano (2014)
10.1074/jbc.271.50.32253
Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit*
L. Huang (1996)
10.1158/1078-0432.CCR-11-3114
The Pancreas Cancer Microenvironment
Christine Feig (2012)
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts.
L. Eikenes (2010)
10.1126/SCIENCE.1104819
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
R. Jain (2005)
10.1073/pnas.1401337111
Engineered nanomedicine for myeloma and bone microenvironment targeting
Archana Swami (2014)
10.1158/1535-7163.MCT-09-0195
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
M. Schmidt (2009)
10.1007/BF00047468
Transport of molecules across tumor vasculature
R. Jain (2004)
10.1021/nn302148p
Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo.
Z. Al-Ahmady (2012)
10.1007/PL00007647
Effect of Hyaluronidase on Albumin Diffusion in Lung Interstitium
X. L. Qiu (1999)
10.1038/nm.2890
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Yu Sun (2012)
10.1039/c5nr01408e
Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Shaobo Ruan (2015)
Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts.
E. Unemori (1990)
10.1172/JCI965
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
G. Thurston (1998)
10.1021/BC0501303
Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes.
Jovita R Tauro (2005)
Relationship between microvessel density and thermographic hot areas in breast cancer
矢原 敏郎 (2003)
10.1039/c3cs60048c
Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Z. Ge (2013)
10.1007/s10439-012-0630-4
Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model
T. Stylianopoulos (2012)
10.1158/1078-0432.CCR-07-1035
Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts
W. Zamboni (2007)
10.1021/nl301206p
Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix.
M. Kanapathipillai (2012)
10.1038/nrclinonc.2010.139
Delivering nanomedicine to solid tumors
R. Jain (2010)
10.1021/mp400216r
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.
Saijie Zhu (2013)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1101/GAD.266803
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.
P. Lindblom (2003)
10.1038/sj.bjc.6602626
Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts
L. Eikenes (2005)
10.1038/370061A0
A matrix metalloproteinase expressed on the surface of invasive tumour cells
H. Sato (1994)
10.1038/nm.1971
Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging
B. Vakoc (2009)
10.1158/1535-7163.MCT-08-1170
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
Aaron M LeBeau (2009)
10.1016/j.addr.2013.09.001
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
Ameya R. Kirtane (2013)
10.4161/cc.21384
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production
Carmela Guido (2012)
10.1146/annurev-bioeng-071811-150124
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
10.1038/427695A
Pathology: Cancer cells compress intratumour vessels
T. Padera (2004)
10.1038/nmeth.1475
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in tumor vascular networks
W. Kamoun (2010)
10.1021/BM0503571
pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study.
V. Sethuraman (2006)
10.1073/pnas.1018892108
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
B. Diop-Frimpong (2011)
10.1016/j.bpj.2009.03.064
Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo.
Vikash P. Chauhan (2009)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
Bridge over troubled waters : understanding the synthetic and biological identities of engineered nanomaterials , Wiley interdisciplinary reviews
N. Feliu (2013)
10.1038/nnano.2011.166
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.
H. Cabral (2011)
10.1016/j.addr.2012.01.020
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
E. Fleige (2012)
10.1016/S0006-3495(99)76911-0
Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations.
A. Pluen (1999)
10.1038/89997
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy
E. Brown (2001)
10.1080/10611860701453034
Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells
P. Baum (2007)
10.1016/J.EJPB.2007.03.023
MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin.
G. Lee (2007)
10.1158/0008-5472.CAN-13-3494
Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment.
K. Yokoi (2014)
10.1016/j.ijpharm.2011.12.015
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex.
M. Kato (2012)
10.1016/j.biomaterials.2012.05.025
Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery.
C. Zhang (2012)
10.1016/j.addr.2011.04.006
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.
Yinghuan Li (2012)
Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure.
E. Sevick (1989)
10.1158/0008-5472.CAN-03-2904
Akt Stimulates Aerobic Glycolysis in Cancer Cells
R. Elstrom (2004)
10.1124/jpet.107.121632
Tumor Priming Enhances Delivery and Efficacy of Nanomedicines
D. Lu (2007)
10.1016/j.jconrel.2012.11.012
Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy.
G. H. Gao (2013)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1021/nn700145v
Cellular internalization and in vivo tracking of thermosensitive luminescent micelles based on luminescent lanthanide chelate.
Yongyong Li (2008)
Increased nanoparticle penetration in collagenase-treated multicellular spheroids
Thomas T. Goodman (2007)
Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.
S. H. Jang (2001)
10.1007/BF01211802
Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo
K. Beckenlehner (2005)
10.1007/s10456-008-9099-z
Vascular permeability, vascular hyperpermeability and angiogenesis
J. Nagy (2008)
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
Y. Wang (2013)
10.1016/j.jconrel.2011.07.031
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
10.1158/2326-6066.CIR-14-0209
Tumors: Wounds That Do Not Heal—Redux
H. Dvorak (2015)
10.1158/1078-0432.CCR-08-2082
Mathematical Modeling of Herpes Simplex Virus Distribution in Solid Tumors: Implications for Cancer Gene Therapy
W. Mok (2009)
10.1016/j.biomaterials.2011.03.050
Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy.
Ziwei Deng (2011)
10.1016/j.pnpbp.2012.12.009
Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus
W. Bild (2013)
10.1248/BPB.35.761
Pericyte-coverage of human tumor vasculature and nanoparticle permeability.
Liuzhe Zhang (2012)
10.1007/s00535-009-0013-2
Signal transduction in pancreatic stellate cells
A. Masamune (2009)
10.1038/nm.2753
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
H. Peinado (2012)
10.1007/s10439-015-1276-9
Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors
T. Stylianopoulos (2015)
10.1016/S0074-7696(08)61334-0
Ultrastructure of basement membranes.
S. Inoue (1989)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
10.1021/nn301282m
Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo.
K. Huang (2012)
10.4161/cc.20718
Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production
C. Capparelli (2012)
10.1002/PPSC.201400169
Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model.
S. Murty (2014)
10.1016/S0002-9440(10)63540-7
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors.
P. Baluk (2003)
10.1016/j.ejpb.2011.12.008
Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticles in pulmonary hypertension.
Venkat Ratnam Devadasu (2012)
10.1038/nnano.2012.45
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Vikash P. Chauhan (2012)
10.1038/nature07424
A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation
J. Greenberg (2008)
10.3389/fphys.2012.00344
Pancreatic stellate cells: a starring role in normal and diseased pancreas
M. Apte (2012)
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
L. Gerweck (1996)
10.1080/10611860500071292
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
T. Göppert (2005)
10.1136/gutjnl-2012-302529
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
M. A. Jacobetz (2012)
10.1016/S0168-3659(02)00374-7
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.
Anupama Potineni (2003)
10.1016/j.jconrel.2008.04.024
Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.
E. Lee (2008)
10.1016/j.nano.2012.07.002
Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure.
Sason Torosean (2013)
10.1016/j.devcel.2011.07.001
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises.
A. Armulik (2011)
10.1016/j.bbcan.2011.10.001
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression.
B. Bauvois (2012)
10.1021/mp100038h
The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles.
H. Lee (2010)
10.1073/pnas.0611660104
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling
M. Kano (2007)
10.1073/pnas.0711961105
PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells
Ru Feng (2008)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1016/S0304-3835(98)00202-X
Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner.
C. Brekken (1998)
10.1002/smll.201301998
In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice.
Joao Paulo Mattos Almeida (2014)
10.1016/S0006-3495(02)73933-7
Diffusion and convection in collagen gels: implications for transport in the tumor interstitium.
S. Ramanujan (2002)
10.1038/nm981
Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors
G. Alexandrakis (2004)
10.1056/NEJM198612253152606
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
H. Dvorak (1986)
Role of extracellular matrix assembly in interstitial transport in solid tumors.
P. A. Netti (2000)
10.2217/nnm.13.212
pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances.
F. Meng (2014)
10.1002/anie.201104449
Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration.
Vikash P. Chauhan (2011)
10.1016/j.bpj.2010.06.016
Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions.
T. Stylianopoulos (2010)
10.4161/onci.27872
Altering the intratumoral localization of macrophages to inhibit cancer progression
A. Casazza (2014)
10.1073/pnas.1117610109
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
Jie-qiong Liu (2012)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.1126/science.1226338
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Z. Cheng (2012)
Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
M. Bae (2003)
10.1073/pnas.1018382108
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff R. Wong (2011)
10.1016/j.bpj.2009.07.009
Selective filtering of particles by the extracellular matrix: an electrostatic bandpass.
O. Lieleg (2009)
10.1016/j.cell.2014.08.007
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
M. Sherman (2014)
10.1016/j.jconrel.2014.10.013
Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.
Z. Al-Ahmady (2014)
10.1158/1538-7445.AM2014-5401
Abstract 5401: Investigation of sub-tumor accumulation of PRINT nanoparticles reveals dose and route of administration dependence on particle association
L. E. Roode (2014)
The effect of nanoparticle size
A. Albanese (2012)
10.1159/000236988
Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
H. Dvorak (1995)
10.1054/bjoc.1999.1171
Vascular permeability in a human tumour xenograft: molecular charge dependence
M. Dellian (2000)
Biocompatible
N. S. Rejinold (2011)
10.1021/nn200876f
Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia.
Zhiyong Poon (2011)
10.1097/00002371-200109000-00002
Cytokines and Immune Response in the Tumor Microenvironment
S. Mocellin (2001)
Determinants of paclitaxel penetration and accumulation in human solid tumor.
H. J. Kuh (1999)
10.1016/j.colsurfb.2014.02.028
Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
I. Levacheva (2014)
10.1021/nn404083m
Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice.
Huan Meng (2013)
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.
M. Leunig (1992)
10.1007/S13233-011-1209-X
Synthesis and micellization of thermosensitive PNIPAAm-b-PLA amphiphilic block copolymers based on a bifunctional initiator
F. Xu (2011)
10.1146/annurev-chembioeng-061010-114300
Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.
Vikash P. Chauhan (2011)
10.1158/1078-0432.CCR-13-1637
Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
N. Smith (2013)
10.1016/j.jconrel.2014.07.058
Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes.
Bilyana M. Dicheva (2014)
10.1002/anie.201100884
Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells.
Kejin Zhou (2011)
10.1002/ijc.29430
Triggered doxorubicin release in solid tumors from thermosensitive liposome‐peptide hybrids: Critical parameters and therapeutic efficacy
Z. Al-Ahmady (2015)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1016/j.jconrel.2014.12.018
Improving drug delivery to solid tumors: priming the tumor microenvironment.
Iftikhar Ali Khawar (2015)
10.1002/wnan.1206
Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.
B. Fadeel (2013)
10.1111/j.1349-7006.2008.01003.x
Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor‐β receptor inhibitor on extravasation of nanoparticles from neovasculature
M. Kano (2009)
10.1016/0925-4773(93)90052-Y
A temperature-sensitive brain tumor suppressor mutation of Drosophila melanogaster: Developmental studies and molecular localization of the gene
E. Gateff (1993)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
10.1084/JEM2093OIA1
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu (2012)
10.1016/j.devcel.2010.05.012
Tumors as organs: complex tissues that interface with the entire organism.
M. Egeblad (2010)
10.1038/nm879
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
E. Brown (2003)
10.1021/JP902637N
Synthesis of Thermo-Sensitive Micellar Aggregates Self-Assembled from Biotinylated PNAS-b-PNIPAAm-b-PCL Triblock Copolymers for Tumor Targeting
Chang-Yun Quan (2009)
10.1016/j.ijbiomac.2011.04.008
Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery.
N. S. Rejinold (2011)
10.1007/s00109-007-0281-3
Hypoxia and cancer
M. Brahimi-Horn (2007)
10.1073/pnas.1318415110
Combining two strategies to improve perfusion and drug delivery in solid tumors
T. Stylianopoulos (2013)
10.1158/0008-5472.CAN-05-2242
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.
T. McKee (2006)
10.2147/IJN.S47129
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
H. Nehoff (2014)
10.1016/S0169-409X(02)00059-5
Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences.
E. Wright (2002)
10.1007/978-3-319-16555-4_9
Exploring the tumor microenvironment with nanoparticles.
L. Miao (2015)
10.1016/j.bcp.2014.02.010
The potential of heparanase as a therapeutic target in cancer.
Claudio Pisano (2014)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
10.1021/nn5010815
Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
S. Guo (2014)
10.1016/j.ajpath.2013.06.026
Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.
T. Mammoto (2013)
10.1021/nn502807n
Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix
A. Parodi (2014)
10.1021/ja300176w
Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli.
Kejin Zhou (2012)
10.1016/S0022-5347(01)62975-6
Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
H. Pham (1997)
10.1016/j.ccr.2014.04.005
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
B. Özdemir (2014)
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks in vivo
W. Kamoun (2010)
10.1016/j.neo.2014.07.003
Tumor Interstitial Fluid Pressure—A Link between Tumor Hypoxia, Microvascular Density, and Lymph Node Metastasis
E. Rofstad (2014)
10.1158/0008-5472.CAN-12-1683
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
A. Manzoor (2012)
10.1038/nrc1456
High interstitial fluid pressure — an obstacle in cancer therapy
C. Heldin (2004)
10.1016/j.addr.2014.05.005
Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
M. Kanapathipillai (2014)
10.1126/SCIENCE.364652
Design of liposomes for enhanced local release of drugs by hyperthermia.
M. Yatvin (1978)
10.1021/mp900009n
Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery.
Jin-Ki Kim (2009)
10.1128/MCB.16.7.3844
Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.
D. Parry (1996)
10.1186/1475-2867-14-41
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
G. Kharaishvili (2013)
10.1158/2159-8290.CD-11-0136
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.
Clifford J Whatcott (2011)
damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT 16 B
D. Baker
10.1016/S1471-4906(02)02302-5
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
A. Mantovani (2002)
10.1016/0140-6736(93)90902-S
Angiogenesis
A. Logan (1993)
10.1634/THEONCOLOGIST.6-5-415
Matrix metalloproteinase inhibitors: current developments and future perspectives.
R. Hoekstra (2001)
10.1016/j.ceb.2010.08.015
Dynamic interplay between the collagen scaffold and tumor evolution.
M. Egeblad (2010)
10.1016/j.jcis.2011.04.006
Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
N. S. Rejinold (2011)
10.1016/j.jconrel.2014.03.016
Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.
J. Zhang (2014)
10.1073/PNAS.86.14.5385
Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching.
S. Chary (1989)
10.1158/0008-5472.CAN-13-0062
Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis.
M. Murakami (2013)
Tunable
K. Zhou (2011)
10.1016/j.biomaterials.2013.11.022
Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.
T. Thambi (2014)
10.1172/JCI26532
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.
M. Loeffler (2006)
10.1158/1078-0432.CCR-14-0493
Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
G. Song (2014)
10.1083/JCB.105.6.2559
Basement membrane structure in situ: evidence for lateral associations in the type IV collagen network
P. Yurchenco (1987)
10.2147/IJN.S3061
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
10.1016/j.bpj.2010.08.065
Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation.
T. Stylianopoulos (2010)
10.1038/nrc1478
Why do cancers have high aerobic glycolysis?
R. Gatenby (2004)
10.1054/DRUP.2000.0119
pH and drug resistance in tumors.
N. Raghunand (2000)



This paper is referenced by
10.1007/s13346-020-00842-0
Candesartan treatment enhances liposome penetration and anti-tumor effect via depletion of tumor stroma and normalization of tumor vessel
Xin-jun Cai (2020)
10.3390/cancers12102785
Angiotensin Inhibition, TGF-β and EMT in Cancer
Fabian Bernhard Pallasch (2020)
10.1002/adma.201904337
Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management.
Da Huo (2019)
10.1016/j.mri.2017.11.008
Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?
Ross A Little (2018)
10.1016/j.drudis.2020.06.029
Engineering extracellular matrix to improve drug delivery for cancer therapy.
Xiaocong He (2020)
10.2967/jnumed.119.241232
FAP: The Next Billion Dollar Nuclear Theranostics Target?
J. Calais (2020)
10.1021/acs.molpharmaceut.7b00475
Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment.
W. Xiao (2017)
10.1002/advs.201902746
MT1‐MMP‐Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy
Y. Wei (2020)
10.1016/J.NANTOD.2017.06.010
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Junjie Liu (2017)
10.1016/j.tips.2017.10.009
Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
Qin Chen (2018)
10.1158/0008-5472.CAN-16-0866
Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
L. Miao (2017)
10.3390/cancers12051189
Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
V. S. Madamsetty (2020)
10.1002/adtp.201800049
Multifunctional Nanotherapeutics for Photothermal Combination Therapy of Cancer
Y. Tian (2018)
10.1016/j.jconrel.2016.09.014
Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
B. Chen (2016)
10.1016/j.addr.2016.04.025
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.
J. I. Hare (2017)
10.1016/j.phrs.2017.05.004
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Shu Yang (2017)
10.7150/thno.16684
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
B. Chen (2017)
10.1016/j.jconrel.2018.09.031
Nano‐targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
D. F. Mardhian (2018)
10.1016/j.msec.2020.111229
Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models.
T. Haider (2020)
10.1016/j.jconrel.2020.10.007
Dictamnine delivered by PLGA nanocarriers ameliorated inflammation in an oxazolone-induced dermatitis mouse model.
Chin-Yu Lin (2020)
10.1016/j.biomaterials.2017.10.014
Physical oncology: New targets for nanomedicine.
A. Nicolas-Boluda (2018)
10.1016/j.biomaterials.2018.03.046
Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy.
C. Hu (2018)
10.1016/J.COBME.2019.01.002
Towards a molecular-level understanding of the protein corona around nanoparticles – Recent advances and persisting challenges
K. Nienhaus (2019)
10.1016/j.jconrel.2019.11.016
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market.
M. Gonçalves (2019)
10.1111/php.13209
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment
Aaron J. Sorrin (2020)
10.1038/s41401-018-0038-2
Asiatic acid enhances intratumor delivery and the antitumor effect of pegylated liposomal doxorubicin by reducing tumor-stroma collagen
L. Fang (2018)
10.1016/j.cmpb.2019.105106
Advances in mathematical models of the active targeting of tumor cells by functional nanoparticles
Y. Gao (2020)
10.1038/s41598-017-08838-6
Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
M. Polasek (2017)
10.1007/978-4-431-56880-3_4
Stromal Barriers Within the Tumor Microenvironment and Obstacles to Nanomedicine
Hiroyoshi Y Tanaka (2019)
Modeling of Anticancer Drug Delivery By Temperature-Sensitive Liposomes
Vera Franziska Loeser (2017)
10.3390/ijms21176029
Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment
Anne-Kathrin Noack (2020)
10.1016/j.biomaterials.2017.11.038
One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy.
Yu Yang (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar